Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

BENZOIN TINCTURE, COMPO

Active
SPE2DP-26-T-4356Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Benzoin Tincture, Compound, USP is an over-the-counter topical product intended for external use only, containing 1000 mg of Benzoin Resin per milliliter as the active ingredient and 77 percent alcohol as an inactive ingredient. It is supplied in 16-ounce bottles, equivalent to one pint or 473 milliliters, and is classified as a flammable substance requiring storage between 20°C and 25°C in accordance with USP controlled room temperature standards. The item has a non-extendable shelf life of 36 months, and any delivery to the first government activity must ensure a minimum of 31 months of remaining shelf life at the time of receipt. This product is regulated by the FDA and is subject to hazardous materials requirements, including the mandatory inclusion of a current Material Safety Data Sheet (MSDS) with every shipment and electronic submission to DLA.MSDS@DLA.MIL using the required cover sheet P-75. Packaging must comply with 49 CFR and ICAO regulations for hazardous materials, and all items must be marked in accordance with Medical Marking Standard No. 1, superseding MIL-STD-129. The item is covered under Defense Information potentially applicable provisions and incorporates technical and quality requirements from the DLA Master List. It is identified by NSN 6505-01-654-9628 under solicitation SPE2DP-26-T-4356, with a 20-day delivery deadline and procurement through the Department of Defense’s Medical Supply Chain.

General Info

Benzoin Tincture, USP, 1000 mg/mL, flammable, 36-month shelf life, 31-month minimum at delivery, hazardous material, NSN 6505-01-654-9628

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

424210 - Drugs and Druggists' Sundries Merchant WholesalersView NAICS

Place of Performance

UNIT 2497 CP 011 496 371 46 2418, APO, AE, 09094-3219, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS

Full Description

Show more
BENZOIN TINCTURE,COMPOUND
BENZOIN TINCTURE,COMPOUND,USP
OVER THE COUNTER (OTC), FOR EXTERNAL
USE ONLY, TOPICAL, CONTAINS 77 PERCENT
ALCOHOL AS AN INACTIVE INGREDIENT.
CONTAINS 1000 MG (1 GRAM) IN 1 ML OF
BENZOIN RESIN AS THE ACTIVE INGREDIENT.
.
UNIT OF ISSUE IS A BOTTLE CONTAINING
16 OUNCES (OR 1 PINT OR 473 ML).
.
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
THERE SHALL BE A MINIMUM OF 31 MONTHS OF REMAINING SHELF LIFE AT THE TIME OF RECEIPT BY THE FIRST GOVERNMENT ACTIVITY. . STORE AT 20° TO 25°C (68° TO 77°F) [SEE USP CONTROLLED ROOM TEMPERATURE] . FLAMMABLE: KEEP AWAY FROM SPARK, HEAT OR FLAME. .
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/ . This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. .
SPE2DP-26-T-4356
SECTION B
.
ITEM HAS FLAMMABLE/COMBUSTIBLE CHARACTERISTICS.
.
.
HAZARDOUS MATERIALS REQUIREMENTS.
.
MATERIAL SAFETY DATA SHEET (MSDS).
.
. A CURRENT MSDS SHALL BE PROVIDED FOR THIS
ITEM. DLA'S DOD HMIRS FOCAL POINT (VBA) HAS
ESTABLISHED AN ELECTRONIC MAILBOX TO WHICH
ONE CAN TRANSMIT THE MSDS, TOGETHER WITH THE
COVER SHEET (P-75) WHOSE CONTENTS ARE TO
REFLECT LOGISTICS INFORMATION PROPER TO THE
MSDS ASSOCIATED WITH THE AWARDED CONTRACT AND
NSN. THE ELECTRONIC MAILBOX ADDRESS IS
DLA.MSDS@DLA.MIL.
.
. IN ADDITION, A COPY OF THE MSDS SHALL
ACCOMPANY EACH SHIPMENT OF THIS ITEM.
.
PACKAGING.
.
. PACKAGING FOR HAZARDOUS MATERIALS SHALL
COMPLY WITH APPLICABLE REGULATIONS, I.E.,
49 CFR, INTERNATIONAL CIVIL AVIATION
ORGANIZATION (ICAO) TECHNICAL NSN/Part Number: 6505-01-654-9628 Quantity: 1 BT Purchase Request: 7017656212QTY: 1 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 424210
New
DIBBS
SUNSCREEN PREPARATION
Solicitation # SPE2DP-26-T-4340
The contract specifies the procurement of a topical sunscreen preparation meeting stringent medical and military standards, containing 4.5% titanium dioxide and 4% zinc oxide with an SPF of 50, designed to be sweat and water-resistant for 80 minutes, hypoallergenic, oil-free, PABA-free, biodegradable, and suitable for outdoor use. Each unit is packaged as a case of 24 three-ounce tubes with a total shelf life of 24 months, requiring a minimum of 21 months of remaining shelf life upon receipt by the first government activity, and must be stored between 15°C and 30°C in a cool, dry environment. The product is regulated by the FDA and must comply with all DLA Master List of Technical and Quality Requirements, which override any other standards including ASTM D3951 and MIL-STD-129. Packaging must adhere to Medical Marking Standard No. 1, with palletization and labeling strictly conforming to DLA’s packaging protocols, and the material is not considered hazardous under FED-STD-313, so commercial packaging per ASTM D3951 applies only where DLA requirements do not take precedence. All shipments must be sent by the fastest traceable means, excluding parcel post, with delivery FOB destination within five days of order, and zero tolerance for quantity variance. Three separate delivery line items total four pallets to be delivered to three distinct military locations: a unit in Melrose, Massachusetts; a unit at Fort Bragg, North Carolina; and the USS Gridley in FPO AP. Each shipment is tied to a unique purchase request and delivery address, with the same NSN material number assigned to all, indicating identical product specifications across all units. The contract requires exact compliance with military marking standards, packaging requirements, and shipping instructions, including adherence to DLA procedures for vessel shipments where applicable. The solicitation number is SPE2DP-26-T-4340, issued by the Department of Defense Medical Supply Chain, with a response deadline of August 3, 2026, and all deliveries must be completed no later than July 30, 2026. The unit of issue is defined as a package, and all packaging details, including quantity per unit pack and palletization, are fixed per contract terms. Manufacturer and bid details must be verified through EBS referral to ensure FDA compliance prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 4 days
View Details
NAICS: 424210
New
DIBBS
HEPARIN SODIUM INJECTI
Solicitation # SPE2DP-26-T-4328
Heparin Sodium Injection USP, supplied in 5000 unit per 1 mL single-use Carpuject syringes, is procured in lots of 50 units per box under contract SPE2DP-26-T-4328 for delivery to Travis Air Force Base, California. The product must meet strict packaging and labeling requirements in accordance with Medical Marking Standard No. 1B dated March 30, 2017, superseding MIL-STD-129, and all packaging must ensure protection against damage during transit. Each unit must be sealed in a suitable container and shipped in commercial exterior containers compliant with ASTM D3951 or FED-STD-313 if classified as hazardous, with palletization adhering to DLA Packaging Requirements RP001. The product must have a minimum shelf life of 24 months from manufacture and no less than 21 months must remain at the time of delivery to the government. Storage requirements specify a temperature range of 20 to 25°C (68 to 77°F) with no freezing permitted. The item is regulated by the FDA and requires pre-delivery referral to a product specialist via EBS. Delivery is FOB destination within 20 days of contract award, with zero tolerance for quantity variance. Shipping must be traceable; parcel post is prohibited. The unit of issue is one package (PG), and the sole contracted supplier is AmerisourceBergen Drug Corp under NDC 00409-1402-12, manufactured by Pfizer Inc. All marking, packaging, and documentation must strictly follow DLA standards, and delivery must occur by the required date of July 29, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 424210
New
DIBBS
SODIUM CHLORIDE INJECT
Solicitation # SPE2DP-26-T-4331
Sodium Chloride Injection USP 0.9% 1000ML IV plastic bag latex free is being procured under solicitation SPE2DP-26-T-4331 with a requirement for two purchase groups (PG), each containing twelve 1000ML units, totaling 24 units. Delivery is due within five days of award, with FOB destination terms mandating that the contractor assumes all transportation costs and risks until delivery is completed at the primary location in Bogalusa, Louisiana, 70427-0000. The product must comply with USP standards and be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), with strict prohibitions against excessive heat and freezing. A non-extendable shelf life of 30 months applies, and the product must be marked per Medical Marking Standard No. 1 (MMS No. 1), which supersedes MIL-STD-129 for all medical acquisitions. Packaging must be commercial and designed to protect against damage during transport, using sealed unit containers inside commercially appropriate shipping containers suitable for common carrier delivery at the lowest rate. The item is regulated by the FDA and classified as a TYPE I (CODE P) item under DLA requirements. Manufacturer identifiers include ICU Medical Sales Inc with NDC00990-7983-09 and B. Braun Medical Inc with NDC00264-5802-00 and Q8000. Contracting officials must initiate an electronic referral in EBS for bidder and manufacturer validation, including part numbers and descriptions. The contract requires electronic submission of invoices and receiving reports via Wide Area WorkFlow (WAWF), with payment instructions governed by DFARS clause 252.232-7006. Inspection and acceptance occur at destination, with the government responsible for final verification of compliance with all technical, packaging, and labeling specifications outlined in MMS No. 1, MIL-STD-2073-1E, and the DLA Master List of Technical and Quality Requirements. The solicitation incorporates multiple FAR and DFARS clauses addressing equal opportunity, trafficking in persons, cybersecurity safeguards, hazardous materials labeling, and prohibitions on covered defense telecommunications equipment and services. Offerors must represent their size status and socioeconomic designation in SAM, provide UEI and CAGE codes if applicable, and disclose any use
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 325412
New
DIBBS
BENZONATATE CAPSULES
Solicitation # SPE2DP-26-T-4357
BENZONATATE CAPSULES, USP, 100 MG, are supplied in bottles of 100 capsules each, with the active ingredient being 100 milligrams of benzonatate per capsule. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F) and protected from light, moisture, and humidity. This item falls under a Type I (Code Q) shelf-life classification with a non-extendable shelf life of 36 months and must be marked in accordance with the latest edition of Medical Marking Standard No. 1. It is regulated by the FDA, and buyers are required to submit a referral via EBS to the product specialist, including bidder and manufacturer details such as names, part numbers, and NDC codes. The item is subject to DLA packaging requirements and technical quality standards referenced in the DLA Master List of Technical and Quality Requirements. The contract specifies delivery of four bottles under purchase request 7017663196, with delivery due within 20 days FOB destination, no variance allowed in quantity, and inspection and acceptance occurring at the destination. The NSN is 6505-00-660-1798, and the solicitation number is SPE2DP-26-T-4357, issued by the Department of Defense’s Medical Supply Chain PHARM FSA, with a response deadline of August 4, 2026. Primary point of contact is Imerah Burnett, and packaging must comply with MIL-STD-2073-1E.
Pharmaceutical Preparation Manufacturing

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
TRICHLOROACETIC ACID
Solicitation # SPE2DP-26-T-4354
The contract specifies the procurement of Trichloroacetic Acid, ACS grade, 80% concentration, in 15 mL units, identified by NSN 6505-01-363-7674 and part number 749887 from AmerisourceBergen Drug Corp. The item is classified as a TYPE I (CODE M) with a non-extendable shelf life of 24 months and must be packaged and marked in full compliance with Medical Marking Standard No. 1, superseding MIL-STD-129. Packaging must meet commercial standards with sealed unit containers and shipping containers capable of preventing damage during transit, ensuring safe delivery by common carrier at the lowest cost to the designated destination in APO, 09094-3219. The item is regulated by the FDA, requiring referral through EBS for confirmation, and delivery must occur within 20 days FOB destination with zero quantity variance allowed. Inspection and acceptance occur at the delivery point. Suppliers must provide Safety Data Sheets (SDS) and labels compliant with OSHA’s revised Hazard Communication Standard (29 C.F.R. 1910.1200), effective June 1, 2015, and must train employees on these requirements. All documentation must align with DLA’s Master List of Technical and Quality Requirements, and the unit of issue is BT, equivalent to 15 mL. The contract is issued under SPE2DP-26-T-4354, with a response deadline of August 4, 2026, and is governed by federal procurement regulations including DLA packaging and hazardous material handling standards.
Pharmaceutical Preparation Manufacturing

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
DIBUCAINE OINTMENT
Solicitation # SPE2DP-26-T-4358
Dibucaine Ointment USP is a topical pharmaceutical product containing one percent dibucaine as the active ingredient, specifically formulated for rectal administration and external use only. It is supplied in a collapsible tube and a rectal applicator, with each unit of issue being a single package containing one ounce or 28 grams of the ointment. Storage requirements mandate a temperature range of 15 to 30 degrees Celsius (59 to 86 degrees Fahrenheit). The product is regulated by the FDA and must be marked in accordance with the latest edition of Medical Marking Standard No. 1, with a non-extendable shelf life of 36 months as a Type I (Code Q) item. Packaging must comply with MIL-STD-2073-1E, and government identification must be removed from any non-accepted supplies. The contract specifies a procurement quantity of two packages, to be delivered FOB destination within 20 days, with zero variance allowed in quantity. The item is identified by NSN 6505002999535 and NDC 00536-1211-95, supplied by The Harvard Drug Group, L.L.C. The solicitation number is SPE2DP-26-T-4358, with a response deadline of August 4, 2026, and the place of performance is Nellis AFB, NV. The contract includes adherence to DLA’s Master List of Technical and Quality Requirements, and buyers must submit referrals in EBS to confirm product compliance prior to award.
Pharmaceutical Preparation Manufacturing

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
New
DIBBS
APPLICATOR, SILVER NITR
Solicitation # SPE2DP-26-Q-0124
The contract calls for the procurement of silver nitrate applicators, each consisting of a 75% silver nitrate and 25% potassium nitrate mixture fused to a 6-inch (1.524 cm) tip, packaged in containers of 100 units, for topical medical use only and regulated by the FDA. All units must be stored in sealed packages at room temperature in a dark, dry location away from oxidizable materials, and the item carries a non-extendable 24-month shelf life as a TYPE I (CODE M) item under DLA’s requirements. The product is identified by NSN 6505-00-299-9672 and is subject to hazardous materials handling protocols, requiring a current Material Safety Data Sheet (MSDS) to accompany each shipment and be submitted electronically to DLA.MSDS@DLA.MIL. Packaging and labeling must strictly comply with MIL-STD-2073-1E and Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical acquisitions, ensuring proper barcoding and inspection readiness. Delivery is to occur within 15 days of an As Directed Order to multiple DoD medical facilities, with FOB destination terms placing responsibility for transportation and risk on the contractor. The contract is firm fixed price, requires electronic invoicing through Wide Area WorkFlow, and mandates adherence to comprehensive cybersecurity, supply chain security, and government information safeguarding protocols including DFARS 252.204-7012 and 252.204-7018. Ocean transportation must use U.S.-flag vessels unless a waiver is secured with 45-day notice and supporting documentation, and contractors must ensure all subcontractors comply with applicable regulations. The solicitation, open for response through August 3, 2026, is issued by the Department of Defense's Medical Supply Chain Pharm FSA through DLA Troop Support, with procurement activities managed under specific FAR and DFARS clauses covering subcontracting, equal opportunity, payment integrity, and prohibitions on foreign-sourced telecommunications and covered applications.

POSTED

about 15 hours ago

DEADLINE

in 4 days
View Details
NAICS: 325412
New
DIBBS
ALBUTEROL SULFATE INHA
Solicitation # SPE2DP-26-T-4353
Albuterol Sulfate Inhalation Aerosol with HFA is a prescription-only medication for oral inhalation, delivering 108 micrograms of albuterol sulfate per actuation, equivalent to 90 micrograms of albuterol base, supplied in an 8.5-gram canister containing 200 metered doses. The product must be stored at room temperature between 59°F and 77°F (15°C and 25°C), protected from extreme heat or cold, with specific warnings against puncturing, exposing to temperatures above 120°F, or spraying into the eyes. It has a non-extendable shelf life of 24 months and is classified as a TYPE I (CODE M) item under the Federal supply system. Labeling must include the National Stock Number, manufacturer date, expiration or retest date, contract number, and lot number, in compliance with the Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards, with each unit sealed in a protective container and shipped in suitable exterior packaging to ensure safe delivery via common carrier. The product is regulated by the FDA and subject to Hazard Communication Standard requirements, mandating submission of Safety Data Sheets and compliant HCS labels aligned with 29 C.F.R. 1910.1200 prior to award, along with employee training on updated chemical labeling protocols. The contract specifies delivery of three units FOB destination within 20 days, with no variance allowed in quantity, and inspection and acceptance occurring at the delivery point. The NSN is 6505-01-543-6562, and the solicitation details identify Teva Pharmaceuticals USA, Inc. and Perrigo Direct Inc. as potential suppliers under procurement number SPE2DP-26-T-4353.
Pharmaceutical Preparation Manufacturing

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
VECURONIUM BROMIDE FOR
Solicitation # SPE2DP-26-T-4359
Vecuronium Bromide for Injection is a freeze-dried powder containing 10 mg of the active ingredient, supplied in packages of ten vials each, with a total shelf life of 24 months. At the time of receipt by the first government activity, the product must have a minimum of 21 months of remaining shelf life. The powder must be stored at controlled room temperature between 20 to 25°C (68 to 77°F) and protected from light, with containers retained in their outer cartons until use. Packaging and labeling must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all units must be sealed and packaged in commercial shipping containers that ensure safe delivery via common carrier at the lowest rate. The product is not considered hazardous under FED-STD-313 and must be packaged in accordance with ASTM D3951, though DLA’s Master List of Technical and Quality Requirements takes precedence. Shipments must be sent by traceable means only; parcel post is prohibited. Deliveries are FOB destination with zero variance allowed, and inspection and acceptance occur upon arrival. The supplier is Hikma Pharmaceuticals USA Inc., with NDC 00143-9234-10, and the contract requires multiple deliveries across different locations and dates in July 2026, totaling eight line items for one or three packages per delivery. All packaging, palletization, and labeling must adhere to DLA Packaging Requirements for Procurement and specific storage and handling instructions.
Pharmaceutical Preparation Manufacturing

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
PETROLATUM, WHITE
Solicitation # SPE2DP-26-T-4355
The contract specifies the procurement of 8 units (TU) of white petrolatum, USP, with each TU equaling 28 milligrams, for a total quantity of 224 milligrams. The material must comply with stringent packaging and marking requirements per the Medical Marking Standard No. 1, replacing all references to MIL-STD-129, and must be packaged in sealed commercial unit containers that protect against damage, with exterior shipping containers ensuring safe, cost-effective delivery to the destination. The item is classified as a TYPE I (CODE Q) with a non-extendable shelf life of 36 months and must be shipped by the fastest traceable means, excluding parcel post. Delivery is required within five days of award under FOB destination terms with zero quantity variance permitted and acceptance occurring at the delivery point. The product must be commercially packaged per ASTM D3951 unless deemed hazardous under FED-STD-313, in which case TQ requirement IP025 applies; however, all DLA Master List of Technical and Quality Requirements override any conflicting standards. Packaging and labeling must reflect the specified unit of issue and quantity per unit pack, and palletization must adhere to DLA packaging guidelines. The delivery address is for the 0182 IN BN 01 HHC INFANTRY BN in Melrose, MA, with the required delivery date set for July 30, 2026, and the contract reference number is SPE2DP-26-T-4355.
Pharmaceutical Preparation Manufacturing

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details